Atherogenic circulating lipoproteins in ischemic stroke
2024

The Role of Lipoproteins in Ischemic Stroke

publication Evidence: moderate

Author Information

Author(s): Benitez Sonia, Puig Núria, Camps-Renom Pol, Sánchez-Quesada José Luis

Primary Institution: Institut de Recerca Hospital de Sant Pau

Hypothesis

How do qualitative alterations of lipoproteins contribute to the development of ischemic stroke?

Conclusion

Qualitative changes in lipoproteins, particularly LDL and HDL, are significant factors in the development and progression of ischemic stroke.

Supporting Evidence

  • LDL can trigger inflammation and atherosclerosis, which are linked to stroke.
  • HDL has protective effects against the harmful actions of LDL.
  • Altered lipoprotein quality is crucial for understanding cardiovascular disease risk.

Takeaway

This study looks at how changes in certain fats in our blood can lead to strokes. It finds that not just how much of these fats we have, but also how they are changed, can affect our risk of having a stroke.

Limitations

The review highlights a lack of extensive studies on lipoprotein alterations specifically in ischemic stroke compared to coronary atherosclerosis.

Digital Object Identifier (DOI)

10.3389/fcvm.2024.1470364

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication